TCRR
TCR2 Therapeutics Inc
Price:  
1.48 
USD
Volume:  
3,913,310.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TCRR Relative Valuation

-6078.6%
Upside

As of 2025-07-11, the Relative Valuation of TCR2 Therapeutics Inc (TCRR) is (88.48) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.48 USD, the upside of TCR2 Therapeutics Inc based on Relative Valuation is -6078.6%.

The range of the Relative Valuation is (58.16) - (112.99) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 13.4x - 27.2x 20.3x
Forward P/E multiples 14.0x - 30.6x 22.3x
Fair Price (58.16) - (112.99) (88.48)
Upside -4029.6% - -7734.7% -6078.6%
1.48 USD
Stock Price
(88.48) USD
Fair Price

TCRR Relative Valuation - Historical P/E Data

Date P/E